NEW YORK (GenomeWeb News) — French molecular diagnostics company IntegraGen said today it has appointed Bernard Courtieu as CEO to help the firm “accelerate its commercial efforts.”
 
“We are on the brink of emerging from a research and services firm … to a company able to quickly deliver innovative products though our pipeline and fuel further discovery,” Courtieu said.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.